Company Filing History:
Years Active: 1995-2023
Title: Kazuhiko Kitagawa: Innovator in Osteoporosis Treatment
Introduction
Kazuhiko Kitagawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the treatment and prevention of osteoporosis. With a total of 3 patents to his name, Kitagawa's work focuses on innovative methods that enhance patient safety and efficacy in treatment.
Latest Patents
One of Kitagawa's latest patents is a method for preventing or treating osteoporosis, characterized by administering teriparatide or a salt thereof at a frequency of twice a week. This method aims to provide an effective solution for treating and preventing osteoporosis while ensuring excellent safety and efficacy. Another notable patent involves sulfonamide compounds, which can be used as effective components of a CaSR antagonizing agent. These compounds promote PTH secretion and are useful in the prophylaxis and treatment of bone disorders, including osteoporosis and bone fractures.
Career Highlights
Throughout his career, Kazuhiko Kitagawa has worked with reputable companies such as Asahi Kasei Pharma Corporation and Max Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative approaches to medical treatments.
Collaborations
Kitagawa has collaborated with notable coworkers, including Kouichi Tukagoshi and Takuya Kitamura. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Kazuhiko Kitagawa's work in the field of osteoporosis treatment showcases his dedication to improving patient outcomes through innovative methods. His contributions continue to influence the medical community and pave the way for future advancements in treatment options.